Skip to content
Tenfell
Awarded contract
Published 21 Jan 2025

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

NHS England · London

Key facts

Awarded
14 Jan 2025
Contract starts
01 Feb 2025
Contract ends
31 May 2026
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 6 suppliers

SupplierValue
Baxter Healthcare Ltd—
Dr Reddy's Laboratories (UK) Ltd—
Thornton & Ross Ltd—
Sun Pharma UK Ltd—
Zentiva Pharma UK Ltd—
Biocon—

Description

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:

CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection

Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.